Novosound Unveils First Ultrasound Blood Pressure Monitor at CES 2025
Novosound, a groundbreaking company in ultrasound sensor development, is poised to make history at CES 2025 in Las Vegas by unveiling its ultrasound blood pressure monitoring technology. This marks a global first for wearables, as Novosound showcases how it has achieved accuracy levels comparable to traditional electronic cuff devices. The demonstration, taking place from January 7th-10th, highlights the miniaturization of its innovative technology into wearable devices capable of tracking blood pressure in real-time.
Dave Hughes, CEO and co-founder of Novosound, explains the potential of their technology: “Our technology has the potential to bridge the gap between individuals, the wearables industry, and healthcare providers. Having a product that continuously tracks blood pressure in real-time is considered by many to be a ‘holy grail’ when it comes to health, and we are proving that ultrasound provides the answer.”
This breakthrough, built on Novosound’s Slanj platform, utilizes thin-film ultrasound technology. It follows the company’s previous successful collaboration with the Texas Medical Center in Houston, where the system was demonstrated in real-world settings, rather than remaining confined to laboratory-based development. Unlike many academic institutions that have focused on lab work, Novosound has shown that its technology works effectively in public spaces, bringing it one step closer to widespread, real-world use.
Novosound’s innovation offers an exciting leap forward in blood pressure monitoring. The wearable ultrasound device allows for continuous, real-time tracking of blood pressure, something that has been a long-sought goal in the healthcare sector. Traditional methods rely on periodic measurements taken by manual or electronic devices. In contrast, Novosound’s technology offers ongoing monitoring, providing data around the clock. Hughes emphasizes the transformative potential of this development: “The ability to monitor on a 24/7 basis, combined with the accuracy of the data, is something that takes things to the next level and will be transformative in healthcare. It will enable early detection of potential health issues and more effective management of hypertension.”
Hypertension, or high blood pressure, is a global health crisis. According to the World Health Organization (WHO), over 1 billion adults aged between 30 and 79 suffer from high blood pressure worldwide. Alarmingly, around 1 in 2 of these individuals are unaware of their condition. Hypertension is a significant cause of premature death, leading to heart attacks, strokes, and other serious health complications. The only way to know whether one has hypertension is to regularly monitor blood pressure, but traditional methods often require visits to healthcare providers.
Blood pressure is measured using two numbers. The first, systolic pressure, represents the force exerted on the arteries when the heart contracts or beats. The second, diastolic pressure, indicates the pressure in the arteries when the heart is resting between beats. High blood pressure is typically diagnosed if the systolic readings are consistently above 140 mmHg and/or the diastolic readings exceed 90 mmHg on two different occasions.
The current method of checking blood pressure is inconvenient and typically requires visits to a healthcare provider, which many people neglect. However, with Novosound’s wearable ultrasound blood pressure monitoring system, individuals could track their blood pressure 24/7, from the comfort of their own homes, enabling earlier detection of hypertension and potentially saving lives. The system has the potential to revolutionize the management of hypertension by providing continuous, accurate data that can be shared with healthcare providers for real-time monitoring and intervention.
Hughes further stresses the significance of the technology: “The ability to continuously track blood pressure with such accuracy, coupled with the ease and accessibility of the wearable device, has the power to shift the way we approach healthcare. By identifying high blood pressure early and enabling better management, we can significantly reduce the risk of life-threatening complications, such as heart disease and stroke.”
This revolutionary technology from Novosound not only has the potential to make personal health monitoring more convenient but also aims to alleviate the global burden of hypertension. If successful, the product will provide an effective, non-invasive, and more accessible way to monitor blood pressure, empowering individuals to take control of their health in real-time.
The launch of Novosound’s ultrasound blood pressure monitoring system at CES 2025 marks an exciting milestone in the wearable tech and healthcare industries. It stands to change the way individuals track and manage their blood pressure, making it more accessible, accurate, and convenient than ever before. As the company moves forward, this development may lead to a new era of continuous health monitoring, offering a glimpse into the future of wearable healthcare technology.
Please find the related post
